Cancer has previously been shown to lead to marked insulin resistance due to blocked insulin-stimulated glucose transport and abolished insulin-induced phosphorylation of AS160Thr642 at multiple phosphorylation sites [48]. The gene discussed is INS; the disease is cancer.